Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
Gillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Nature Communications
|
April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients
Philipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Frontiers in Oncology
|
November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Advances in Radiation Oncology
|
June 1, 2022
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Lotte van der Weijst, David Azria, Patrick Berkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, et al.
Frontiers in Oncology
|
November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 25, 2022
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Sarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2024
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study
Miguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 2022
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
Gillian C Barnett, Sarah L Kerns, Leila Dorling, et al.
Nature Communications
|
April 22, 2026
Genetic determinants of fatigue up to 2 years after radiotherapy in prostate cancer patients
Philipp Heumann, Miguel E Aguado-Barrera, Harkeran K Jandu, et al.
Frontiers in Oncology
|
November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer
Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Advances in Radiation Oncology
|
June 1, 2022
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 4, 2022
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Lotte van der Weijst, David Azria, Patrick Berkovic, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 10, 2021
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Nicola Rares Franco, Michela Carlotta Massi, Francesca Ieva, et al.
Frontiers in Oncology
|
November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort
Michela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 25, 2022
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Sarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2024
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study
Miguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, et al.
Page
of 6